| Literature DB >> 33329634 |
Dominik Modrzejewski1, Frank Hartung1, Heike Lehnert1, Thorben Sprink1, Christian Kohl1, Jens Keilwagen1, Ralf Wilhelm1.
Abstract
CRISPR/Cas enables a targeted modification of DNA sequences. Despite their ease and efficient use, one limitation is the potential occurrence of associated off-target effects. This systematic review aims to answer the following research question: Which factors affect the occurrence of off-target effects caused by the use of CRISPR/Cas in plants? Literature published until March 2019 was considered for this review. Articles were screened for relevance based on pre-defined inclusion criteria. Relevant studies were subject to critical appraisal. All studies included in the systematic review were synthesized in a narrative report, but studies rated as high and medium/high validity were reported separately from studies rated as low and medium/low or unclear validity. In addition, we ran a binary logistic regression analysis to verify five factors that may affect the occurrence of off-target effects: (1) Number of mismatches (2) Position of mismatches (3) GC-content of the targeting sequence (4) Altered nuclease variants (5) Delivery methods. In total, 180 relevant articles were included in this review containing 468 studies therein. Seventy nine percentage of these studies were rated as having high or medium/high validity. Within these studies, 6,416 potential off-target sequences were assessed for the occurrence of off-target effects. Results clearly indicate that an increased number of mismatches between the on-target and potential off-target sequence steeply decreases the likelihood of off-target effects. The observed rate of off-target effects decreased from 59% when there is one mismatch between the on-target and off-target sequences toward 0% when four or more mismatches exist. In addition, mismatch/es located within the first eight nucleotides proximal to the PAM significantly decreased the occurrence of off-target effects. There is no evidence that the GC-content significantly affects off-target effects. The database regarding the impact of the nuclease variant and the delivery method is very poor as the majority of studies applied the standard nuclease SpCas9 and the CRISPR/Cas system was stably delivered in the genome. Hence, a general significant impact of these two factors on the occurrence of off-target effects cannot be proved. This identified evidence gap needs to be filled by systematic studies exploring these individual factors in sufficient numbers.Entities:
Keywords: evidence synthesis; genome editing; new plant breeding technique; off-target mutation; systematic literature search; systematic review and meta-analysis; unintended effects
Year: 2020 PMID: 33329634 PMCID: PMC7719684 DOI: 10.3389/fpls.2020.574959
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Figure 1Flow diagram of the systematic mapping process explaining the selection of relevant articles and studies. This diagram follows ROSES guidance (Haddaway et al., 2018).
Overview about the extracted data within the systematic map and further data that were additionally extracted for the systematic review.
| Bibliographic information | - Abstract | None |
| Population | Plant species | None |
| Intervention | Genome editing technique (e.g., CRISPR/Cas) | - Specification of the nuclease variant (e.g., SpCas9, SaCas9, Cpf1) |
| Transformation | None | - Delivery method (DNA-stable, DNA-transient, RNA, Ribonucleoproteins) (RNP) |
| Protospacer | None | Guanin-cytosine (GC)-content of the target sequence |
| Target sequence | Sequence identifier (Name of the gene) | - Different sgRNAs targeting one gene were extracted separately (each sgRNA in one row) |
| Off-target prediction | - Number of identified potential off-target sequences | None |
| Off-target detection | - Detection method | None |
| - Number of analyzed off-target sequences | - Number of mismatches | |
| Identified off-target effects | Off-targets identified (Yes/No) | - Number of identified off-targets, |
Study validity assessment criteria.
| Did the CRISPR/Cas technique induce any on-target mutation? | Any on-target mutation was induced | – | No on-target mutation was induced | Lacking sufficient information to judge |
| Is a reference genome of the edited plant available? | Reference genome is available | – | Reference genome has not been fully sequenced/Sequencing error when analyzing potential off-target sequences | Lacking sufficient information to judge |
| Did a PAM follow the potential off-target sequences?* | All potential off-target sequences were followed by a PAM | Some potential off-target sequences were followed by a PAM | No potential off-target sequences were followed by a PAM | Lacking sufficient information to judge |
| Has the potential off-target sequence at least one mismatch to the on-target site | All potential off-target sequences have at least one mismatch | Some potential off-target sequences have at least one mismatch | All potential off-target sequences have no mismatch | Lacking sufficient information to judge |
| Are information about the potential off-target sequences provided? (number of mismatches, the position of mismatches to the PAM) | All information are provided | Information are partly provided | No information are provided | – |
Overall assessment of study validity.
| Did the CRISPR/Cas technique induce any on-target mutation? |
| Did a PAM follow the potential off-target sequences? |
| Has the potential off-target sequence at least one mismatch to the on-target site? |
| Is a reference genome of the edited plant available? |
| Did sequencing errors occur? |
| Are information about the potential off-target sequences provided? (number of mismatches, the position of mismatches to the PAM) |
| Did a PAM follow the potential off-target sequences? |
| Has the potential off-target sequence at least one mismatch to the on-target site |
| Are information about the potential off-target sequences provided? (number of mismatches, the position of mismatches to the PAM) |
| Did a PAM follow the potential off-target sequences? |
| Has the potential off-target sequence at least one mismatch to the on-target site |
| Are information about the potential off-target sequences provided? (number of mismatches, the position of mismatches to the PAM) |
| Did a PAM follow the potential off-target sequences? |
| Has the potential off-target sequence at least one mismatch to the on-target site |
| Are information about the potential off-target sequences provided? (number of mismatches, the position of mismatches to the PAM) |
Description of independent Variables.
| x1 | Number of mismatches | One mismatch | 1 | 154 | 11 |
| Two mismatches | 2 | 218 | 16 | ||
| Three mismatches | 3 | 352 | 25 | ||
| Four or more mismatches | ≥4 | 671 | 48 | ||
| x2 | Position mismatch/es proximal to the PAM | (Any) mismatch within the seed sequence (Position 1-8 proximal to the PAM) | Yes | 862 | 62 |
| Any mismatch/es within the seed sequence | No | 533 | 38 | ||
| x3 | GC-content | <50% | Low | 505 | 36 |
| ≥50% | High | 890 | 64 | ||
| x4 | Delivery method | DNA-stable | DNA-stable | 1,229 | 88 |
| Others (DNA-transient, RNP, RNA) | Others | 166 | 12 | ||
| x5 | Nuclease variant | CRISPR/SpCas9 | SpCas9 | 1,218 | 87 |
| Further Nucleases | Others | 177 | 13 |
Overview on the validity assessment of all studies and the reason for validation.
| 326 | All study validity assessment criteria were rated as “Yes” | ||
| 44 | Some potential off-target sequences were followed by a PAM ( | ||
| 72 | No on-target mutation was induced ( | ||
| 26 | Lacking sufficient information to judge ( |
Overview about the characteristic items and frequency of studies rated as high and medium/high validity.
| 370 | SpCas9 | 311 | DNA-stable | 283 | 5,999 | |
| DNA-transient | 18 | 78 | ||||
| RNPs | 8 | 133 | ||||
| RNA | 2 | 9 | ||||
| Cpf1 | 20 | DNA-stable | 20 | 62 | ||
| eSpCas9 (1.1) | 8 | DNA-stable | 4 | 26 | ||
| DNA-transient | 4 | 7 | ||||
| eSpCas9 (1.0) | 8 | DNA-stable | 3 | 24 | ||
| DNA-transient | 5 | 8 | ||||
| SaCas9 | 6 | DNA-stable | 2 | 5 | ||
| DNA-transient | 4 | 4 | ||||
| Others | 17 | DNA-stable | 9 | 47 | ||
| DNA-transient | 8 | 14 |
RNP, Ribonucleoproteins; RNA, Ribonucleic acid.
Figure 2Effect summary of the binary regression analysis for the full model, the reduced model, and the final model. The LogWorth transformation adjusts P-value to provide an appropriate scale for graphing. A value that exceeds 2 is significant.
Odds ratios for number of mismatches and mismatch/es within seed sequence.
| 2 | 1 | 0.2661273 | <0.0001 | 0.1661508 | 0.4262619 |
| 3 | 1 | 0.0272239 | <0.0001 | 0.0135418 | 0.05473 |
| 3 | 2 | 0.1022967 | <0.0001 | 0.0515393 | 0.2030414 |
| ≥4 | 1 | 0.0062283 | <0.0001 | 0.0024145 | 0.016066 |
| ≥4 | 2 | 0.0234035 | <0.0001 | 0.009159 | 0.0598016 |
| ≥4 | 3 | 0.2287805 | 0.0069 | 0.0784442 | 0.6672328 |
| 1 | 2 | 3.7576002 | <0.0001 | 2.3459754 | 6.0186306 |
| 1 | 3 | 36.732378 | <0.0001 | 18.271515 | 73.845412 |
| 2 | 3 | 9.7754885 | <0.0001 | 4.9251049 | 19.402668 |
| 1 | ≥4 | 160.55728 | <0.0001 | 62.243085 | 414.16069 |
| 2 | ≥4 | 42.728674 | <0.0001 | 16.72197 | 109.18209 |
| 3 | ≥4 | 4.3710014 | 0.0069 | 1.4987273 | 12.747919 |
| No | Yes | 0.48958322 | <0.0001 | 3.1263158 | 7.6669071 |
| Yes | No | 0.2042554 | <0.0001 | 0.1304307 | 0.3198653 |
Figure 3Percentage of detected off-target effects for one (n = 154), two (n = 218), three (n = 356), and four or more (n = 5,688) mismatches. Calculation: Number of detected off-target effects/number of analyzed potential off-target sequences.
Figure 4Percentage of detected off-target effects for one mismatch based on the position the mismatch is located proximal to the PAM. The guide sequence is divided in five intervals of four nucleotides each (Position 1–4 proximal to the PAM, position 5–8, 9–12, 13–16, 17–21. Yellow: Number of studies with detected off-target effects; blue: Number of studies without detected off-target effects; Red: Percentage of detected off-target effects for each interval.
Figure 5Incidence of off-target effects when two mismatches occur proximal to the PAM. (x/y): (“x” off-target effects identified/“y” potential off-target sequences analyzed).
Figure 6Rate of identified off-target effects assessing potential off-target sequences with (A) one mismatch (B) two mismatches (C) one and two mismatches to the target sequence considering the GC-content of the protospacer.
Overview about the characteristics of analyzed potential off-target sequences using different nuclease variants.
| SpCas9 | 311 | 6,219 | 1 mismatch | 95 | 54 |
| 2 mismatches | 147 | 35 | |||
| 3 mismatches | 344 | 10 | |||
| ≥4 mismatches | 5,628 | 5 | |||
| Cpf1 | 20 | 62 | 1 mismatch | 4 | 3 |
| 2 mismatches | 3 | 0 | |||
| 3 mismatches | 4 | 0 | |||
| ≥4 mismatches | 51 | 0 | |||
| eSpCas9 (1.1) | 8 | 33 | 1 mismatch | 9 | 6 |
| 2 mismatches | 21 | 9 | |||
| 3 mismatches | 3 | 1 | |||
| ≥4 mismatches | 0 | – | |||
| eSpCas9 (1.0) | 8 | 32 | 1 mismatch | 10 | 8 |
| 2 mismatches | 21 | 8 | |||
| 3 mismatches | 1 | 0 | |||
| ≥4 mismatches | 0 | – | |||
| SaCas9 | 6 | 9 | 1 mismatch | 4 | 4 |
| 2 mismatches | 1 | 0 | |||
| 3 mismatches | 0 | – | |||
| ≥4 mismatches | 4 | 0 | |||
| Others | 17 | 61 | 1 mismatch | 32 | 18 |
| 2 mismatches | 25 | 5 | |||
| 3 mismatches | 4 | 0 | |||
| ≥4 mismatches | 0 | – |
Overview about the characteristics of analyzed potential off-target sequences using delivery methods to deliver the CRISPR system into the plant cells.
| DNA-stable | 321 | 6,163 | 1 mismatch | 101 | 52 |
| 2 mismatches | 207 | 55 | |||
| 3 mismatches | 323 | 9 | |||
| ≥4 mismatches | 5,532 | 4 | |||
| DNA-transient | 39 | 111 | 1 mismatch | 51 | 39 |
| 2 mismatches | 7 | 1 | |||
| 3 mismatches | 18 | 2 | |||
| ≥4 mismatches | 35 | 1 | |||
| RNP | 8 | 133 | 1 mismatch | 1 | 1 |
| 2 mismatches | 4 | 1 | |||
| 3 mismatches | 13 | 0 | |||
| ≥4 mismatches | 115 | 0 | |||
| RNA | 2 | 9 | 1 mismatch | 1 | 1 |
| 2 mismatches | 0 | – | |||
| 3 mismatches | 2 | 0 | |||
| ≥4 mismatches | 6 | 0 |
RNP, Ribonucleoproteins; DNA, deoxyribonucleic acid; RNA, ribonucleic acid.